As of today (2026-06-25), the Forward Annual Dividend Yield of Roche Holding AG is 3.01%.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Roche Holding AG is 3.01%.
XSWX:ROP's Forward Dividend Yield % is ranked better than 66.8% of 503
companies
in the Drug Manufacturers industry
Industry Median: 2.1
vs XSWX:ROP: 3.01
During the past 12 months, Roche Holding AG's average Dividends Per Share Growth Rate was 1.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 1.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 1.60% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 2.20% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Roche Holding AG was 32.00% per year. The lowest was 1.20% per year. And the median was 7.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Roche Holding AG (XSWX:ROP) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Roche Holding AG Forward Dividend Yield % Related Terms
XSWX:ROP vs LLY, JNJ, ABBV: Forward Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Roche Holding AG's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Roche Holding AG Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Roche Holding AG's Forward Dividend Yield % falls into.
Roche Holding AG Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Roche Holding AG Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CHF 9.800000
2026-03-12
2026-03-13
2026-03-16
Cash Dividend
annually
CHF:CHF 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Roche Holding AG's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
9.8
/
332.00
=
2.95 %
Current Share Price is CHF332.00. Roche Holding AG's Dividends per Share for the forward twelve months is calculated as CHF9.8 * 1 = CHF9.8.
Roche Holding AG's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 3.01% mean?
Roche Holding AG (XSWX:ROP) has a Forward Dividend Yield % of 3.01% as of Jun. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Roche Holding AG and its competitors. According to the industry distribution chart, Roche Holding AG ranks #167 out of 503 companies in the Drug Manufacturers industry, placing it in the top 33.2%.
Is Roche Holding AG's Forward Dividend Yield % too high?
Roche Holding AG's current Forward Dividend Yield % is 3.01%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.10. Roche Holding AG's value of 3.01% is 43.3% above this industry median. Based on the distribution chart, Roche Holding AG ranks #167 out of 503 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Roche Holding AG has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's Forward Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Roche Holding AG ranks #167 out of 503 companies for Forward Dividend Yield %. This puts Roche Holding AG in the upper half of its industry. The industry median Forward Dividend Yield % is 2.10. Roche Holding AG's value of 3.01% is 43.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.10, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Roche Holding AG's current Forward Dividend Yield % of 3.01% is 43.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Roche Holding AG and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Roche Holding AG's current Forward Dividend Yield % is 3.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (XSWX:ROP) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF264.69, compared to a current price of CHF332.00 — trading 25.4% above its estimated fair value. The current Forward Dividend Yield % is 3.01% and 43.3% above the Drug Manufacturers industry median of 2.10. Roche Holding AG's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Roche Holding AG (XSWX:ROP), the current Forward Dividend Yield % is 3.01% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Roche Holding AG (XSWX:ROP) Overvalued in 2026?
Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued.
The current stock price of CHF332.00 is trading 25.4% above its estimated GF Value™ of CHF264.69.
GuruFocus considers Roche Holding AG to be Modestly Overvalued.
Key valuation signals for XSWX:ROP:
Forward Dividend Yield %: 3.01%
GF Value™: CHF264.69 vs. price of CHF332.00 (25.4% above fair value)
Industry Position: 43.3% above the Drug Manufacturers median (#167 of 503)
No single metric tells the full story. See the XSWX:ROP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
79GF Score
Get the complete analysis for XSWX:ROP
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ROP has been successfully added to your 